Floatz logo

Therapeutic Asset Ratings

3,774 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Adenovirus Specific T- Lymphocytes
Cytomegalovirus Infection
Jessie L. AlexanderP1/2CCC (48)
Adenovirus Specific T- Lymphocytes
Epstein-Barr Virus Infection
Jessie L. AlexanderP1/2CCC (48)
Admsc
Cognitive Disorder
Paul E SchulzP1/2CCC (48)
Adoptive Therapy With Autologous Mc2 Tcr T Cells
Uveal Melanoma
Erasmus Medical CenterP1/2CCC (48)
Allo-501A
B-Cell Non-Hodgkin Lymphoma
Allogene TherapeuticsP1/2CCC (48)
Allogeneic Anti-Ny-Eso-1-Tcr-Il-15-Transduced Cord Blood-Derived Natural Killer Cells
Plasma Cell Myeloma
M.D. Anderson Cancer CenterP1/2CCC (48)
Allogeneic Car19 Regulatory T Cells
Hematopoietic And Lymphoid System Neoplasm
Masonic Cancer Center, University of MinnesotaP1/2CCC (48)
ALLOGENEIC HUMAN UMBILICAL CORD BLOOD
Chronic Myelomonocytic Leukemia
The First Affiliated Hospital with Nanjing Medical UniversityP1/2CCC (48)
Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells
Cirrhosis Of Liver
PT. Prodia Stem Cell IndonesiaP1/2CCC (48)
Allogeneic T Cell Progenitors, Cultured Ex-Vivo
Hematopoietic And Lymphoid System Neoplasm
Smart Immune SASP1/2CCC (48)
Allogenic Cd19 Car-̸̸̸̸T Cell
Non-Hodgkin Lymphoma
Chinese PLA General HospitalP1/2CCC (48)
Allogenic Nk Cells
Acute Myeloid Leukemia
Xuzhou Medical UniversityP1/2CCC (48)
Allo-Quadcar01-T
Leukemia
AvenCell Therapeutics, Inc.P1/2CCC (48)
Allo-Quadcar01-T
Diffuse Large B-Cell Lymphoma
AvenCell Therapeutics, Inc.P1/2CCC (48)
Allo-Quadcar01-T
Lymphoma
AvenCell Therapeutics, Inc.P1/2CCC (48)
Anti-Cd19 Anti-Cd20 Bispecific Car-T
B-Cell Acute Lymphoblastic Leukemia
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyP1/2CCC (48)
Anti-Cd19 Autologous Car-T Cell Infusion
B-Cell Neoplasm
920th Hospital of Joint Logistics Support Force of People's Liberation Army of ChinaP1/2CCC (48)
Anti-Cd19/Cd22 Car-T Cells
Diffuse Large B Cell Lymphoma
First Affiliated Hospital Xi'an Jiaotong UniversityP1/2CCC (48)
Anti-Cd19 Ucar-Nk Cells
B-Cell Acute Lymphoblastic Leukemia
920th Hospital of Joint Logistics Support Force of People's Liberation Army of ChinaP1/2CCC (48)
Anti-Steap1 Car T-Cells
Castration-Resistant Prostate Carcinoma
Fred Hutchinson Cancer CenterP1/2CCC (48)
Autologous Cd19-Directed Chimeric Antigen Receptor T-Cells
Adult Acute Lymphoblastic Leukemia
University of AlbertaP1/2CCC (48)
Autologous Cd19-Directed Chimeric Antigen Receptor T-Cells
Non-Hodgkin Lymphoma
University of AlbertaP1/2CCC (48)
Autologous Cd19-Directed Chimeric Antigen Receptor T-Cells
Childhood Acute Lymphoblastic Leukemia
University of AlbertaP1/2CCC (48)
Autologous Cd1C+ /Cd141+ Mydc
Metastases to Soft Tissue
Universitair Ziekenhuis BrusselP1/2CCC (48)
Autologous Dual-Target Car-T Cells Selected From The Predefined Target Library.
Refractory Malignant Neoplasm
Beijing BiotechP1/2CCC (48)
Showing 626 to 650 of 3,774 assets
PreviousPage 26 of 151Next